2. China/HK Investments in U.S. CRE
Source: RCA, Cushman & Wakefield Research
Deals over $5 million. Where there were multiple buyers, deal volume was distributed evenly (e.g. if there were two buyers, then each was given 50% deal credit)

3. China/HK Investments in U.S. CRE by Location
Source: RCA, Cushman & Wakefield Research
Deals over $5 million. Where there were multiple buyers, deal volume was distributed evenly (e.g. if there were two buyers, then each was given 50% deal credit)

4. China/HK Investments in U.S. CRE by Investor
Source: RCA, Cushman & Wakefield Research
Deals over $5 million. Where there were multiple buyers, deal volume was distributed evenly (e.g. if there were two buyers, then each was given 50% deal credit)

5. China/HK Investments in U.S. CRE by Property Type
Source: RCA, Cushman & Wakefield Research
Deals over $5 million. Where there were multiple buyers, deal volume was distributed evenly (e.g. if there were two buyers, then each was given 50% deal credit)

6. China/HK Investment in NYC Metro by Property Type
Source: RCA, Cushman & Wakefield Research
Deals over $5 million. Where there were multiple buyers, deal volume was distributed evenly (e.g. if there were two buyers, then each was given 50% deal credit)

7. China/HK Investment in SF Metro by Property Type
Source: RCA, Cushman & Wakefield Research
Deals over $5 million. Where there were multiple buyers, deal volume was distributed evenly (e.g. if there were two buyers, then each was given 50% deal credit)

8. China/HK Investment in LA Metro by Property Type
Source: RCA, Cushman & Wakefield Research
Deals over $5 million. Where there were multiple buyers, deal volume was distributed evenly (e.g. if there were two buyers, then each was given 50% deal credit)

9. China/HK Investment in Chicago/Seattle by Property Type
Source: RCA, Cushman & Wakefield Research
Deals over $5 million. Where there were multiple buyers, deal volume was distributed evenly (e.g. if there were two buyers, then each was given 50% deal credit)

10. Top 10 U.S. CRE Transactions 2017*
Source: RCA, Cushman & Wakefield Research
Grey = China/HK investor. *Includes value of medical properties not included elsewhere in this report.

11. Top 10 China/HK Inbound Transactions of 2017*
Source: RCA, Cushman & Wakefield Research
*Includes value of medical properties not included elsewhere in this report.